Inventor
Debashis MANDAL
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds25%
C07CAcyclic or carbocyclic compounds13%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
PatentTitleYear
12,226,425Inhibitors of ARG1 and/or ARG2202512,195,447Azolopyrimidine for the treatment of cancer-related disorders202512,103,907Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha202412,064,433Pyridone A2R antagonists202411,931,343CD73 inhibitors202411,787,762Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha202311,407,712Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2a2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to ARCUS BIOSCIENCES INC (7)· patent assignee history
2022–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ARCUS BIOSCIENCES INC | 7 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2022–2025 |